BRISTOL-MYERS SQUIBB CO (1BMY.MI) Fundamental Analysis & Valuation
BIT:1BMY • US1101221083
Current stock price
50.65 EUR
-2.15 (-4.07%)
Last:
This 1BMY.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. 1BMY.MI Profitability Analysis
1.1 Basic Checks
- In the past year 1BMY was profitable.
- In the past year 1BMY had a positive cash flow from operations.
- Of the past 5 years 1BMY 4 years were profitable.
- In the past 5 years 1BMY always reported a positive cash flow from operatings.
1.2 Ratios
- 1BMY has a better Return On Assets (7.83%) than 61.22% of its industry peers.
- With an excellent Return On Equity value of 38.19%, 1BMY belongs to the best of the industry, outperforming 91.84% of the companies in the same industry.
- The Return On Invested Capital of 1BMY (19.52%) is better than 81.63% of its industry peers.
- 1BMY had an Average Return On Invested Capital over the past 3 years of 14.47%. This is in line with the industry average of 14.21%.
- The last Return On Invested Capital (19.52%) for 1BMY is above the 3 year average (14.47%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.83% | ||
| ROE | 38.19% | ||
| ROIC | 19.52% |
ROA(3y)2.2%
ROA(5y)3.91%
ROE(3y)3.56%
ROE(5y)10.1%
ROIC(3y)14.47%
ROIC(5y)12.91%
1.3 Margins
- With a decent Profit Margin value of 14.64%, 1BMY is doing good in the industry, outperforming 63.27% of the companies in the same industry.
- In the last couple of years the Profit Margin of 1BMY has grown nicely.
- 1BMY has a better Operating Margin (35.82%) than 89.80% of its industry peers.
- 1BMY's Operating Margin has improved in the last couple of years.
- The Gross Margin of 1BMY (72.63%) is comparable to the rest of the industry.
- 1BMY's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 35.82% | ||
| PM (TTM) | 14.64% | ||
| GM | 72.63% |
OM growth 3Y13.23%
OM growth 5Y20.59%
PM growth 3Y2.21%
PM growth 5YN/A
GM growth 3Y-2.43%
GM growth 5Y-0.33%
2. 1BMY.MI Health Analysis
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so 1BMY is creating value.
- Compared to 1 year ago, 1BMY has more shares outstanding
- Compared to 5 years ago, 1BMY has less shares outstanding
- 1BMY has a better debt/assets ratio than last year.
2.2 Solvency
- 1BMY has an Altman-Z score of 2.52. This is not the best score and indicates that 1BMY is in the grey zone with still only limited risk for bankruptcy at the moment.
- 1BMY's Altman-Z score of 2.52 is in line compared to the rest of the industry. 1BMY outperforms 46.94% of its industry peers.
- 1BMY has a debt to FCF ratio of 3.51. This is a good value and a sign of high solvency as 1BMY would need 3.51 years to pay back of all of its debts.
- Looking at the Debt to FCF ratio, with a value of 3.51, 1BMY is in the better half of the industry, outperforming 65.31% of the companies in the same industry.
- 1BMY has a Debt/Equity ratio of 2.33. This is a high value indicating a heavy dependency on external financing.
- The Debt to Equity ratio of 1BMY (2.33) is worse than 77.55% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.33 | ||
| Debt/FCF | 3.51 | ||
| Altman-Z | 2.52 |
ROIC/WACC2.18
WACC8.96%
2.3 Liquidity
- 1BMY has a Current Ratio of 1.26. This is a normal value and indicates that 1BMY is financially healthy and should not expect problems in meeting its short term obligations.
- 1BMY has a Current ratio (1.26) which is in line with its industry peers.
- A Quick Ratio of 1.14 indicates that 1BMY should not have too much problems paying its short term obligations.
- 1BMY has a better Quick ratio (1.14) than 67.35% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.26 | ||
| Quick Ratio | 1.14 |
3. 1BMY.MI Growth Analysis
3.1 Past
- 1BMY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 439.47%, which is quite impressive.
- Measured over the past years, 1BMY shows a decrease in Earnings Per Share. The EPS has been decreasing by -0.92% on average per year.
- Looking at the last year, 1BMY shows a decrease in Revenue. The Revenue has decreased by -0.22% in the last year.
- 1BMY shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.54% yearly.
EPS 1Y (TTM)439.47%
EPS 3Y-7.62%
EPS 5Y-0.92%
EPS Q2Q%-24.55%
Revenue 1Y (TTM)-0.22%
Revenue growth 3Y1.45%
Revenue growth 5Y2.54%
Sales Q2Q%1.3%
3.2 Future
- Based on estimates for the next years, 1BMY will show a decrease in Earnings Per Share. The EPS will decrease by -4.15% on average per year.
- Based on estimates for the next years, 1BMY will show a decrease in Revenue. The Revenue will decrease by -5.54% on average per year.
EPS Next Y2.98%
EPS Next 2Y0.29%
EPS Next 3Y-4.05%
EPS Next 5Y-4.15%
Revenue Next Year-1.84%
Revenue Next 2Y-1.98%
Revenue Next 3Y-5.39%
Revenue Next 5Y-5.54%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. 1BMY.MI Valuation Analysis
4.1 Price/Earnings Ratio
- 1BMY is valuated reasonably with a Price/Earnings ratio of 9.63.
- Compared to the rest of the industry, the Price/Earnings ratio of 1BMY indicates a rather cheap valuation: 1BMY is cheaper than 89.80% of the companies listed in the same industry.
- Compared to an average S&P500 Price/Earnings ratio of 26.77, 1BMY is valued rather cheaply.
- A Price/Forward Earnings ratio of 9.36 indicates a reasonable valuation of 1BMY.
- 1BMY's Price/Forward Earnings ratio is rather cheap when compared to the industry. 1BMY is cheaper than 83.67% of the companies in the same industry.
- When comparing the Price/Forward Earnings ratio of 1BMY to the average of the S&P500 Index (21.75), we can say 1BMY is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.63 | ||
| Fwd PE | 9.36 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, 1BMY is valued cheaper than 85.71% of the companies in the same industry.
- 1BMY's Price/Free Cash Flow ratio is rather cheap when compared to the industry. 1BMY is cheaper than 95.92% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 9.4 | ||
| EV/EBITDA | 7.26 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates 1BMY does not grow enough to justify the current Price/Earnings ratio.
- 1BMY has an outstanding profitability rating, which may justify a higher PE ratio.
- 1BMY's earnings are expected to decrease with -4.05% in the coming years. This may justify a cheaper valuation.
PEG (NY)3.24
PEG (5Y)N/A
EPS Next 2Y0.29%
EPS Next 3Y-4.05%
5. 1BMY.MI Dividend Analysis
5.1 Amount
- With a Yearly Dividend Yield of 4.27%, 1BMY is a good candidate for dividend investing.
- Compared to an average industry Dividend Yield of 1.96, 1BMY pays a better dividend. On top of this 1BMY pays more dividend than 81.63% of the companies listed in the same industry.
- 1BMY's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.27% |
5.2 History
- The dividend of 1BMY is nicely growing with an annual growth rate of 6.51%!
Dividend Growth(5Y)6.51%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
- 71.52% of the earnings are spent on dividend by 1BMY. This is not a sustainable payout ratio.
- 1BMY's earnings are declining while the Dividend Rate has been growing. This means the dividend growth is most likely not sustainable.
DP71.52%
EPS Next 2Y0.29%
EPS Next 3Y-4.05%
1BMY.MI Fundamentals: All Metrics, Ratios and Statistics
BIT:1BMY (4/20/2026, 7:00:00 PM)
50.65
-2.15 (-4.07%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Industry Strength65.84
Industry Growth15.53
Earnings (Last)02-05 2026-02-05/bmo
Earnings (Next)04-30 2026-04-30
Inst Owners83.3%
Inst Owner ChangeN/A
Ins Owners0.02%
Ins Owner ChangeN/A
Market Cap103.15B
Revenue(TTM)48.19B
Net Income(TTM)7.05B
Analysts70.56
Price Target52.72 (4.09%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.27% |
Yearly Dividend2.19
Dividend Growth(5Y)6.51%
DP71.52%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)9.39%
Min EPS beat(2)6.92%
Max EPS beat(2)11.85%
EPS beat(4)4
Avg EPS beat(4)18.29%
Min EPS beat(4)6.92%
Max EPS beat(4)35.04%
EPS beat(8)8
Avg EPS beat(8)16.75%
EPS beat(12)11
Avg EPS beat(12)12.26%
EPS beat(16)15
Avg EPS beat(16)10.82%
Revenue beat(2)2
Avg Revenue beat(2)1.61%
Min Revenue beat(2)0.79%
Max Revenue beat(2)2.43%
Revenue beat(4)4
Avg Revenue beat(4)3.42%
Min Revenue beat(4)0.79%
Max Revenue beat(4)6.79%
Revenue beat(8)8
Avg Revenue beat(8)3.86%
Revenue beat(12)9
Avg Revenue beat(12)1.94%
Revenue beat(16)12
Avg Revenue beat(16)1.77%
PT rev (1m)8.14%
PT rev (3m)16.41%
EPS NQ rev (1m)1.09%
EPS NQ rev (3m)-4.14%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.15%
Revenue NQ rev (1m)3.32%
Revenue NQ rev (3m)2.22%
Revenue NY rev (1m)6.63%
Revenue NY rev (3m)6.92%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.63 | ||
| Fwd PE | 9.36 | ||
| P/S | 2.5 | ||
| P/FCF | 9.4 | ||
| P/OCF | 8.53 | ||
| P/B | 6.53 | ||
| P/tB | N/A | ||
| EV/EBITDA | 7.26 |
EPS(TTM)5.26
EY10.38%
EPS(NY)5.41
Fwd EY10.68%
FCF(TTM)5.39
FCFY10.64%
OCF(TTM)5.94
OCFY11.73%
SpS20.22
BVpS7.75
TBVpS-9.39
PEG (NY)3.24
PEG (5Y)N/A
Graham Number30.2889 (-40.2%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.83% | ||
| ROE | 38.19% | ||
| ROCE | 25.91% | ||
| ROIC | 19.52% | ||
| ROICexc | 23.22% | ||
| ROICexgc | 84.94% | ||
| OM | 35.82% | ||
| PM (TTM) | 14.64% | ||
| GM | 72.63% | ||
| FCFM | 26.65% |
ROA(3y)2.2%
ROA(5y)3.91%
ROE(3y)3.56%
ROE(5y)10.1%
ROIC(3y)14.47%
ROIC(5y)12.91%
ROICexc(3y)17.24%
ROICexc(5y)15.38%
ROICexgc(3y)72.12%
ROICexgc(5y)85.46%
ROCE(3y)19.19%
ROCE(5y)17.14%
ROICexgc growth 3Y-3.78%
ROICexgc growth 5Y13.73%
ROICexc growth 3Y21.19%
ROICexc growth 5Y33.96%
OM growth 3Y13.23%
OM growth 5Y20.59%
PM growth 3Y2.21%
PM growth 5YN/A
GM growth 3Y-2.43%
GM growth 5Y-0.33%
F-Score7
Asset Turnover0.54
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.33 | ||
| Debt/FCF | 3.51 | ||
| Debt/EBITDA | 2.03 | ||
| Cap/Depr | 32.69% | ||
| Cap/Sales | 2.72% | ||
| Interest Coverage | 8.22 | ||
| Cash Conversion | 66.54% | ||
| Profit Quality | 182.1% | ||
| Current Ratio | 1.26 | ||
| Quick Ratio | 1.14 | ||
| Altman-Z | 2.52 |
F-Score7
WACC8.96%
ROIC/WACC2.18
Cap/Depr(3y)19.36%
Cap/Depr(5y)15.61%
Cap/Sales(3y)2.66%
Cap/Sales(5y)2.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)439.47%
EPS 3Y-7.62%
EPS 5Y-0.92%
EPS Q2Q%-24.55%
EPS Next Y2.98%
EPS Next 2Y0.29%
EPS Next 3Y-4.05%
EPS Next 5Y-4.15%
Revenue 1Y (TTM)-0.22%
Revenue growth 3Y1.45%
Revenue growth 5Y2.54%
Sales Q2Q%1.3%
Revenue Next Year-1.84%
Revenue Next 2Y-1.98%
Revenue Next 3Y-5.39%
Revenue Next 5Y-5.54%
EBIT growth 1Y49.54%
EBIT growth 3Y14.87%
EBIT growth 5Y23.65%
EBIT Next Year23.75%
EBIT Next 3Y2.42%
EBIT Next 5Y-1.47%
FCF growth 1Y-7.87%
FCF growth 3Y2.44%
FCF growth 5Y-0.69%
OCF growth 1Y-6.81%
OCF growth 3Y2.71%
OCF growth 5Y0.15%
BRISTOL-MYERS SQUIBB CO / 1BMY.MI Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for BRISTOL-MYERS SQUIBB CO?
ChartMill assigns a fundamental rating of 6 / 10 to 1BMY.MI.
Can you provide the valuation status for BRISTOL-MYERS SQUIBB CO?
ChartMill assigns a valuation rating of 8 / 10 to BRISTOL-MYERS SQUIBB CO (1BMY.MI). This can be considered as Undervalued.
What is the profitability of 1BMY stock?
BRISTOL-MYERS SQUIBB CO (1BMY.MI) has a profitability rating of 8 / 10.
Can you provide the PE and PB ratios for 1BMY stock?
The Price/Earnings (PE) ratio for BRISTOL-MYERS SQUIBB CO (1BMY.MI) is 9.63 and the Price/Book (PB) ratio is 6.53.
What is the financial health of BRISTOL-MYERS SQUIBB CO (1BMY.MI) stock?
The financial health rating of BRISTOL-MYERS SQUIBB CO (1BMY.MI) is 5 / 10.